Potential of 1-(1-napthylmethyl)-piperazine, an efflux pump inhibitor against cadmium-induced multidrug resistance in Salmonella enterica serovar Typhi as an adjunct to antibiotics.
Cadmium adaptation
Efflux pump inhibitors
Ethidium bromide assay
Gene expression
Synergy
Toxicity
Journal
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
ISSN: 1678-4405
Titre abrégé: Braz J Microbiol
Pays: Brazil
ID NLM: 101095924
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
17
10
2020
accepted:
06
04
2021
pubmed:
15
4
2021
medline:
15
12
2021
entrez:
14
4
2021
Statut:
ppublish
Résumé
This study was focused on elucidating inhibition of antibiotic efflux mechanism of cadmium adapted (CdA) Salmonella Typhi Ty2 cells. Herein, upregulated expression of efflux genes (acrB, tolC) and their regulators (soxS, marA) was observed in CdA Ty2 cells by qRT-PCR. The pathogen further elevated the expression of these genes even in the presence of three efflux pump inhibitors (EPIs), i.e., Phe-Arg-β-naphthylamide, 1-(1-naphthyl-methyl)piperazine, and 5-hydroxy-2-methyl-1,4-naphthoquinone, perhaps by sensing the pressure of the latter in addition to cadmium stress. Interaction of different EPIs with efflux pumps of CdA Ty2 cells was confirmed using ethidium bromide (EtBr) accumulation and efflux assay. All the EPIs could cause retention of EtBr which was indicated by increased fluorescence units. Considering this potential of EPIs, retention of antibiotics was evaluated in CdA Ty2 cells wherein EPIs were used in combination with selected antibiotics (instead of EtBr). A decrease in the effective concentration of antibiotics was observed. This was further validated using the clinical isolates. The data revealed the efficiency of EPIs as they could inhibit the efflux potential of even the overexpressed efflux pumps. Thus, combination of EPI(s)-antibiotics may be exploited in future as one of the strategies for combating metal induced antibiotic resistance.
Identifiants
pubmed: 33851343
doi: 10.1007/s42770-021-00492-5
pii: 10.1007/s42770-021-00492-5
pmc: PMC8324649
doi:
Substances chimiques
Anti-Bacterial Agents
0
Cadmium
00BH33GNGH
Piperazine
1RTM4PAL0V
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1303-1313Informations de copyright
© 2021. Sociedade Brasileira de Microbiologia.
Références
Sci Rep. 2019 Dec 5;9(1):18404
pubmed: 31804525
Antimicrob Agents Chemother. 1997 Oct;41(10):2067-75
pubmed: 9333027
J Biol Eng. 2009 Oct 16;3:18
pubmed: 19835592
J Biol Chem. 1997 Dec 12;272(50):31609-16
pubmed: 9395500
FEMS Immunol Med Microbiol. 2006 Jul;47(2):278-86
pubmed: 16831216
BMC Infect Dis. 2016 Sep 02;16:465
pubmed: 27590053
Antimicrob Agents Chemother. 2005 Jan;49(1):421-4
pubmed: 15616325
Microb Pathog. 2018 Nov;124:11-20
pubmed: 30118800
FEMS Microbiol Lett. 2000 Jun 15;187(2):185-8
pubmed: 10856655
FEMS Microbiol Rev. 2003 Jun;27(2-3):313-39
pubmed: 12829273
PLoS One. 2011;6(7):e22833
pubmed: 21829527
Antimicrob Agents Chemother. 2009 Mar;53(3):1080-7
pubmed: 19104017
Front Microbiol. 2019 Feb 13;10:92
pubmed: 30814979
J Antimicrob Chemother. 2008 May;61(5):1076-82
pubmed: 18310137
Appl Environ Microbiol. 1998 Nov;64(11):4317-20
pubmed: 9797283
Eur J Med Chem. 2013 Aug;66:499-507
pubmed: 23832254
Trends Mol Med. 2005 Aug;11(8):382-9
pubmed: 15996519
Microb Drug Resist. 2002 Winter;8(4):281-9
pubmed: 12523625
J Biol Chem. 2004 Mar 5;279(10):8761-8
pubmed: 14679195
Microbiol Immunol. 2000;44(1):41-50
pubmed: 10711598
J Antimicrob Chemother. 2006 Feb;57(2):344-8
pubmed: 16354746
J Microbiol. 2017 Sep;55(9):737-744
pubmed: 28779338
Virulence. 2013 Apr 1;4(3):223-9
pubmed: 23380871
Front Microbiol. 2015 Apr 28;6:377
pubmed: 25972857
Microbiol Res. 2014 May-Jun;169(5-6):417-24
pubmed: 24103863
BMC Pharmacol Toxicol. 2016 Nov 14;17(1):50
pubmed: 27839515
Microbiology (Reading). 2002 Aug;148(Pt 8):2371-2381
pubmed: 12177331
J Biomed Sci. 2010 Nov 09;17:84
pubmed: 21059273
Microorganisms. 2016 Feb 16;4(1):
pubmed: 27681908
Cytometry. 1994 Dec 1;17(4):302-9
pubmed: 7875037
Microbiologyopen. 2014 Dec;3(6):885-96
pubmed: 25224951
Clin Microbiol Rev. 2015 Apr;28(2):337-418
pubmed: 25788514
Front Microbiol. 2015 May 05;6:421
pubmed: 25999939
Sci Rep. 2018 Aug 24;8(1):12818
pubmed: 30143701
Front Microbiol. 2016 Sep 21;7:1483
pubmed: 27708632
Antimicrob Agents Chemother. 2004 Apr;48(4):1145-50
pubmed: 15047514
Braz J Infect Dis. 2013 Mar-Apr;17(2):125-30
pubmed: 23453941